Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Combined tDCS and Cognitive Neurorehabilitation in Post-Stroke Depression

NCT: NCT07848919 · COMPLETED

NCT IDNCT07848919
StatusCOMPLETED
Start Date2024-04-09
Completion2026-04-17
SponsorInstitut de Recerca Biomèdica de Lleida-Fundació Dr. Pifarré (IRBLleida) (OTHER)
First posted
Last updated

Brief Summary

This study evaluates a multimodal intervention pathway for affective and cognitive symptoms after ischemic stroke. Patients undergo an initial screening of depressive symptoms, cognitive function, and quality of life. Participants meeting the criteria for intervention are randomized to one of four groups: active transcranial direct current stimulation (tDCS), sham tDCS, online cognitive neurorehabilitation, or a combined intervention using active tDCS and online cognitive neurorehabilitation. Clinical outcomes include depressive symptoms, cognitive performance, and quality of life assessed longitudinally during follow-up.

Frequently Asked Questions

What is Combined tDCS and Cognitive Neurorehabilitation in Post-Stroke Depression?

Combined tDCS and Cognitive Neurorehabilitation in Post-Stroke Depression is a clinical trial registered under NCT07848919. Current status: COMPLETED.

What is the status of NCT07848919?

The current status of NCT07848919 (Combined tDCS and Cognitive Neurorehabilitation in Post-Stroke Depression) is: COMPLETED.

When did Combined tDCS and Cognitive Neurorehabilitation in Post-Stroke Depression start?

Combined tDCS and Cognitive Neurorehabilitation in Post-Stroke Depression started on 2024-04-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑